Wang F - Search Results

1

Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage.

Muhanna N, Cui L, Chan H, Burgess L, Jin CS, MacDonald TD, Huynh E, Wang F, Chen J, Irish JC, Zheng G. Muhanna N, et al. Among authors: wang f. Clin Cancer Res. 2016 Feb 15;22(4):961-70. doi: 10.1158/1078-0432.CCR-15-1235. Epub 2015 Oct 13. Clin Cancer Res. 2016. PMID: 26463705

2

Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.

Liu Z, Liu Y, Jia B, Zhao H, Jin X, Li F, Chen X, Wang F. Liu Z, et al. Among authors: wang f. Mol Cancer Ther. 2010 Aug;9(8):2297-308. doi: 10.1158/1535-7163.MCT-10-0444. Epub 2010 Aug 3. Mol Cancer Ther. 2010. PMID: 20682654 Free PMC article.

3

Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer.

Shi J, Liu TW, Chen J, Green D, Jaffray D, Wilson BC, Wang F, Zheng G. Shi J, et al. Among authors: wang f. Theranostics. 2011;1:363-70. doi: 10.7150/thno/v01p0363. Epub 2011 Sep 15. Theranostics. 2011. PMID: 21938264 Free PMC article.

4

PET tracers based on (86)Y.

Huang J, Cui L, Wang F, Liu Z. Huang J, et al. Among authors: wang f. Curr Radiopharm. 2011 Apr;4(2):122-30. doi: 10.2174/1874471011104020122. Curr Radiopharm. 2011. PMID: 22191651 Review.

5

99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.

Liu Z, Huang J, Dong C, Cui L, Jin X, Jia B, Zhu Z, Li F, Wang F. Liu Z, et al. Among authors: wang f. Mol Pharm. 2012 May 7;9(5):1409-17. doi: 10.1021/mp200661t. Epub 2012 Apr 11. Mol Pharm. 2012. PMID: 22452411

6

Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapy.

Cui L, Liu Z, Jin X, Jia B, Li F, Wang F. Cui L, et al. Among authors: wang f. Nucl Med Biol. 2013 Feb;40(2):182-9. doi: 10.1016/j.nucmedbio.2012.11.002. Epub 2012 Nov 28. Nucl Med Biol. 2013. PMID: 23199569

7

Technetium 99m-labeled VQ peptide: a new imaging agent for the early detection of tumors or premalignancies.

Shi J, Cui L, Jia B, Liu Z, He P, Dong C, Jin X, Zhao H, Li F, Wang F. Shi J, et al. Among authors: wang f. Mol Imaging. 2013 Jul-Aug;12(5):318-26. Mol Imaging. 2013. PMID: 23759372

8

(99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.

Dong C, Zhao H, Yang S, Shi J, Huang J, Cui L, Zhong L, Jin X, Li F, Liu Z, Jia B, Wang F. Dong C, et al. Among authors: wang f. Mol Pharm. 2013 Aug 5;10(8):2925-33. doi: 10.1021/mp400040z. Epub 2013 Jun 28. Mol Pharm. 2013. PMID: 23768172

9

Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.

Jin CS, Cui L, Wang F, Chen J, Zheng G. Jin CS, et al. Among authors: wang f. Adv Healthc Mater. 2014 Aug;3(8):1240-9. doi: 10.1002/adhm.201300651. Epub 2014 Jan 27. Adv Healthc Mater. 2014. PMID: 24464930

10

Molecular imaging reveals trastuzumab-induced epidermal growth factor receptor downregulation in vivo.

Ma T, Sun X, Cui L, Gao L, Wu Y, Liu H, Zhu Z, Wang F, Liu Z. Ma T, et al. Among authors: wang f. J Nucl Med. 2014 Jun;55(6):1002-7. doi: 10.2967/jnumed.114.137000. Epub 2014 Apr 14. J Nucl Med. 2014. PMID: 24732154 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,180 results

Search Page

Filters